Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series

Successful treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate: A case series

Abstract Cutaneous leishmaniasis (CL) is a high-morbidity, vector-borne disease endemic to Colombia. Unlike conventional systemic antileishmanial therapy, intralesional meglumine antimoniate administration has fewer adverse effects and can be as effective and safe. We describe 12 patients treated wi...

Full description

Bibliographic Details
Main Authors:	Margarita Arboleda, Santiago Barrantes, Luz Yaned Úsuga, Sara María Robledo
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Medicina Tropical (SBMT) 2019-05-01
Series:	Revista da Sociedade Brasileira de Medicina Tropical
Subjects:	Cutaneous leishmaniasis Intralesional meglumine antimoniate infusion Treatment
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822019000100713&lng=en&tlng=en

Similar Items

Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
by: Maria Cristina de Oliveira Duque, et al.

Intralesional treatment with meglumine antimoniate in three patients with New World cutaneous leishmaniasis and large periarticular lesions with comorbidities
by: Maria Inês Fernandes Pimentel, et al.

Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre
by: Rosiana Estéfane da Silva, et al.
Published: (2016-08-01)

Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial
by: Dario Brock Ramalho, et al.
Published: (2018-06-01)

Towards a standard protocol for antimony intralesional infiltration technique for cutaneous leishmaniasis treatment
by: Rosiana Estéfane da Silva, et al.

Treatment of cutaneous leishmaniasis with combination of allopurinol and low dose of meglumine antimoniate
by: A Momeni, et al.
Published: (2001-03-01)

The pulsed dye laser is more effective and rapidly acting than intralesional meglumine antimoniate therapy for cutaneous leishmaniasis
by: Mohammad Radmanesh, et al.
Published: (2017-07-01)

Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
by: Deninson Alejandro Vargas, et al.
Published: (2019-06-01)

ELECTROCARDIOGRAPHIC CHANGES WITH STANDARD DOSE OF MEGLUMINE ANTIMONIATE THERAPY IN CUTANEOUS LEISHMANIASIS
by: Moizza Tahir, et al.
Published: (2021-08-01)

COMPARISON OF ORAL CHLOROQUINE WITH SYSTEMIC MEGLUMINE ANTIMONIATE IN TREATMENT OF CUTANEOUS LEISHMANIASIS
by: Muhammad Farooq, et al.
Published: (2021-02-01)

Treatment of cutaneous leishmaniasis: cassia fistula fruit gel- intralesional glucantime Vs. placebo gel- intralesional glucantime combination
by: Jaffary F, et al.
Published: (2010-01-01)

New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate
by: Najla Daadaa, et al.
Published: (2021-03-01)

Antimonial treatment failure rate in patients with cutaneous leishmaniasis
by: Fariba Jaffary, et al.
Published: (2018-06-01)

Retrospective study of 151 patients with cutaneous leishmaniasis treated with meglumine antimoniate
by: Armando de Oliveira Schubach, et al.
Published: (2005-05-01)

Intralesional Meglumine Antimoniate: Safe, Feasible and Effective Therapy for Cutaneous Leishmaniasis in Bolivia
by: Ernesto Rojas Cabrera, et al.
Published: (2022-10-01)

Pharmacokinetics of neutron-irradiated meglumine antimoniate in Leishmania amazonensis-infected BALB/c mice
by: Samanta Etel Treiger Borborema, et al.
Published: (2019-03-01)

The Additive Effect of Topical Ciprofloxacin 2% on Intralesional Glucantime Injection in Treatment of Cutaneous Leishmaniasis
by: Mohamadjavad Yazdanpanah, et al.
Published: (2020-06-01)

The Efficacy of Intralesional Meglumine Antimoniate (Glucantime) versus a Combination of Topical Trichloroacetic Acid 50% and Local Heat Therapy by Non-Ablative Radiofrequency on Cutaneous Leishmaniasis Lesions
by: Mohammad Ali Nilforoushzadeh, et al.
Published: (2011-12-01)

Novel methods for the encapsulation of meglumine antimoniate into liposomes
by: F. Frézard, et al.
Published: (2000-07-01)

Immunomodulatory effects of topical diphencyprone for the treatment of acute urban cutaneous leishmaniasis
by: Yalda Nahidi, et al.
Published: (2021-02-01)

Hypersensitivity eosinophilic myocarditis possibly triggered by meglumine antimoniate
by: Sergio A. Bolivar-Lozano, et al.
Published: (2024-03-01)

Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis
by: Diana Berenguer, et al.
Published: (2019-11-01)

Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia
by: Maria del Mar Castro, et al.
Published: (2022-03-01)

Comparison between topical treatment with thioxolone , benzoxonium chloride tincture and intralesional injection of meglumine antymoniate on cutaneous leishmaniasis
by: M.H Daei-Parizi, et al.
Published: (1995-12-01)

Low dose systemic or intralesional meglumine antimoniate treatment for American tegumentary leishmaniasis results in low lethality, low incidence of relapse, and low late mucosal involvement in a referral centre in Rio de Janeiro, Brazil (2001-2013)
by: Lucia Regina Brahim, et al.

Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate
by: D.A. Schettini, et al.
Published: (2005-12-01)

The Efficacy of Carbon Dioxide Laser in the Treatment of Chronic and Lupoid Cutaneous Leishmaniasis in Kerman City: A Randomized Clinical Trial
by: I Esfandiarpour, et al.
Published: (2014-07-01)

The Efficacy, Relapse and Failure in the Treatment of Anthroponotic Cutaneous Leishmaniosis with Intralesional Glucantime Along with Cryotherapy
by: Mehran Karvar, et al.
Published: (2016-03-01)

The Evaluation of Intralesional Glucantime and Cryotherapy plus Intralesional Glucantime Therapeutic Efficacy on Zoonotic Cutaneous Leishmaniasis: A Randomized Clinical Trial
by: Abedin Saghafipour, et al.
Published: (2017-12-01)

Pentavalent Antimonials: New Perspectives for Old Drugs
by: Raul R. Ribeiro, et al.
Published: (2009-06-01)

Intralesional 8.33% Rifamycin infiltration; New treatment for cutaneous leishmaniasis
by: Nameer K. Al-Sudany, et al.
Published: (2016-01-01)

The Potential Use of Methotrexate in the Treatment of Cutaneous Leishmaniasis: In Vitro Assays against Sensitive and Meglumine Antimoniate-resistant Strains of Leishmania tropica
by: Hossein MAHMOUDVAND, et al.
Published: (2017-09-01)

Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis
by: Vahid Mashayekhi Goyonlo, et al.
Published: (2014-01-01)

In vitro and in vivo activity of meglumine antimoniate produced at Farmanguinhos-Fiocruz, Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis
by: Eliane de Morais-Teixeira, et al.
Published: (2008-06-01)

Distribution of liposome-encapsulated antimony in dogs
by: D.A. Schettini, et al.
Published: (2003-02-01)

Fatores associados ao insucesso do tratamento da leishmaniose cutânea com antimoniato de meglumina Factors associated with treatmet failure of cutaneous leishmaniasis with meglumine antimoniate
by: Alex Miranda Rodrigues, et al.
Published: (2006-04-01)

Association of miltefosine with granulocyte and macrophage colony-stimulating factor (GM-CSF) in the treatment of cutaneous leishmaniasis in the Amazon region: A randomized and controlled trial
by: Luciana Mendes, et al.
Published: (2021-02-01)

A Promising Cutaneous Leishmaniasis Treatment with a Nanoemulsion-Based Cream with a Generic Pentavalent Antimony (Ulamina) as the Active Ingredient
by: Johnny Bullón, et al.
Published: (2021-12-01)

Poor response to azithromycin in cutaneous leishmaniasis leading to a premature interruption of a multicentric phase III clinical trial in Brazil
by: Antonio Toledo Junior, et al.
Published: (2014-12-01)

Efficacy of the treatment using a microemulsion loaded with epoxy-α-lapachone in combination with meglumine antimoniate against murine infection by Leishmania (Leishmania) amazonensis
by: Juliana Figueiredo Peixoto, et al.
Published: (2024-04-01)